Ocular Therapeutix Inc. - notizie pubblicate 203 - letture 2.577
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Bedford, mass., july 18, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul) ("ocular"), a biopharmaceutical company committed to enhancing people's vision an ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Announces Late-Breaking Abstract of HELIOS Study to be Presented at 42nd ASRS Annual Scientific Meeting
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Initial Registration Statement for Employee Benefit Plan Form S 8
As filed with the securities and exchange commission on june 17, 2024 registration no. 333-_____ united states securities and exchange commission washington, d.c. 20549 form s-8 re ...
OCULAR THERAPEUTIX INC.
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. on june 12, 2024, ocula ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL 1 Enrollment and Plans for Repeat Dosing Study (SOL R) in wet AMD at Investor Day, Along with Positive 48 week Data from HELIOS NPDR Study
151 subjects enrolled in various stages of loading and randomization in sol-1 pivotal study of axpaxli in wet amd as of june 7, 2024 announces plans for sol-r study to evaluate rep ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix® to Host Investor Day on June 13, 2024
Company to highlight corporate strategy, clinical data, and development plans for axpaxli™ in wet amd and npdr event to feature prominent retinal disease experts baruch d. kupper ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bedford, mass., june 04, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul) ("ocular"), a biopharmaceutical company committed to enhancing people's vision an ...
OCULAR THERAPEUTIX INC.
Costs Associated with Exit/Disposal - Form 8-K
Item 2.05 costs associated with exit or disposal activities. on may 29, 2024, the board of directors (the "board") of ocular therapeutix, inc. (the "company") a ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti